IBD Slides
"Breaking the Barriers: An Update on the Management of IBD and Navigating the PA Process for Small Molecule and Biologics" Meeting Series
2021 National Conference Slide Library
Staying Healthy in GI Disease: A Look at Lifestyle Modifications to Improve GERD and Constipation
Mary Clarke, CNP
Staying Healthy in Inflammatory Bowel Disease (IBD)
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Gastroesophageal Reflux Disease versus Functional Dyspepsia versus Gastroparesis
Monica Nandwani, DNP, RN, FNP- BC
Diagnosis & Management of Chronic Constipation & Dyssynergic Defecation
A Stepwise Approach
Amy Kassebaum-Ladewski, PA-C, MMS, RD
Masqueraders of IBS Recognizing and Managing Congenital Sucrase Isomaltase Deficiency in Clinic Practice
Carol Antequera, DMSc , PA-C
Research Committee Highlights
Chair: Barbra Cave, PhD, APRN
Co-chair: Glenda Quinones, MSN, APRN, DNPc
Acute Alcoholic Hepatitis: Utilizing Prognostic Scores
for Management
HoChong Gilles, DNP, FNP-BC, AF-AASLD
Management of Hyponatremia in Patients With Cirrhosis
Amanda Chaney, DNP, APRN, FAANP, AF-AASLD
Jessica Crimaldi, MSN, APRN, CMSRN
TIPS Procedure: Determining Appropriate Candidates
Whitney Steinmetz, DNP, FNP
Carolyn Catalano, FNP
Thromboembolism in Liver Disease – To Treat or Not to Treat?
K. Tuesday Werner, DNP,
AGACNP/FNP-BC, AFAASLD
Chronic hepatitis C: Access to
treatment and elimination strategies
Michelle Barnett, PA-C, DFAAPA
Allison Hobbs, MSN, APRN-C
Diagnosis & Management of Fecal Incontinence: Obstetric Injury & Defecation Issues
Susan T. Wolgamott, DNP, FNP-C, CTN-B
GHAPP 2021 Conference Virtual Poster Display
LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects With NAFLD and T2D
Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Part A of a Randomized, Placebo-Controlled, Three-Part, Phase 3 Study
Absence of Bowel Urgency is Associated with Significantly Improved Inflammatory Bowel Disease Related Quality of Life in a Phase 2 Trial of Mirikizumabin Patients with Ulcerative Colitis
Disease burden and care-seeking behavior for IBS-C patients in the United States in the era of COVID-19
Rapid Onset of Time to First Spontaneous Bowel Movement (SBM) and Predictable Efficacy of Naloxegol: Pooled Analysis of Two Global Randomized Controlled Trials
Efficacy and Safety of Mirikizumab(LY3074828) After 12 Weeks Induction Treatment in a Phase 2 Study of Patients with Crohn’s Disease
A Single-Center Continuous Quality Improvement Program Identifies 660 Hepatitis C Infected Persons in One Year
Dupilumab Reduces Symptom Burden and Improves Health-Related Quality of Life in Patients With Eosinophilic Esophagitis: Results From Part A of a Randomized, Placebo-Controlled, Three-Part, Phase 3 Study
Safety, Tolerability, and Biological Activity of AXA1125 and AXA1957 in a Prospective 16-Week Randomized, Placebo-Controlled Study in Subjects With NAFLD With and Without Type 2 Diabetes
Mirikizumab Therapy is Associated with Improved Fatigue in Patients with Moderately to Severely Active Crohn’s Disease
Pitfalls of Physician-Directed Treatment of Helicobacter pylori Infection: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data
_Poster.jpg)
MirikizumabTreatment Improves Bowel Movement Urgency in Patients with Moderately to Severely Active Ulcerative Colitis
.jpg)
Impact of Treatment With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate on Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B
_Poster.jpg)
Efficacy and Safety of MirikizumabAfter 52-Weeks Maintenance Treatment in Patients with Moderate-to-Severe Crohn’s Disease
2020 National Conference Slide Library
Use of Noninvasive Markers for Fibrosis and Steatohepatitis
Ngoc Duong, PA-C
Lisa Richards, FNP-BC
Gut Feelings – Yoga and Breath Practices as Complementary Therapy
Christina Unger, MSN, CRNP-BC, RYT
Agents in Clinical Development for other Chronic Liver Diseases HBV and PSC
Elizabeth K. Goacher, PA-C, MHS, AF-AASLD
GHAPP ACADEMY EDUCATION
The GHAPP Academy is a robust training tool for APPs new to the fields of gastroenterology and hepatology. It features incremental, interactive courses that cover the topics essential to each specialty.
New Webcasts
Previous Webcasts
